Walking speed predicts metabolic health in obese individuals
The speed at which people walk can provide insights into health, extending beyond mere mobility, according to experts in Japan. Past studies have suggested that a slow walking… read more.
The speed at which people walk can provide insights into health, extending beyond mere mobility, according to experts in Japan. Past studies have suggested that a slow walking… read more.
Increasing cigarette prices over the past several years have seen more older Australians turn to cannabis use as an alternative, according to new research from Curtin University in… read more.
Organon announced that the FDA has approved Vtama (tapinarof) cream, 1%, an aryl hydrocarbon receptor agonist, for an additional indication of the topical treatment of atopic dermatitis (AD)… read more.
Cumulative exposure to air pollution over several years is linked to a heightened risk of admission to hospital for mental/behavioural and physical illness, finds Scottish research published in… read more.
The European Medicines Agency rounded off a busy year by approving seventeen new medicines. At its December meeting, the Committee for Medicinal Products for Human Use (CHMP) also… read more.
LivaNova PLC announced that the journal Brain Stimulation has published two pivotal articles chronicling the unipolar cohort data set for the RECOVER clinical study. The researchers evaluated the… read more.
Atogepant, an oral drug approved to prevent migraine, appears to also alleviate migraine symptoms early after onset has begun. The findings were reported on December 23, 2024 in… read more.
The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have published a comprehensive overhaul of their guidance on the identification of commercially confidential information (CCI) and… read more.
AstraZeneca PLC’s anticoagulant reversal agent Andexxa (andexanet) will not convert to full approval, after the FDA issued a complete response letter for the supplemental biologics license application. The… read more.
A meta-analysis of data from 14 studies suggests that consumption of coffee and tea is linked to a reduced risk of head and neck cancer, including cancers of… read more.
The European Medicines Agency has approved more than 100 new medicines for the first time in fifteen years. Of the 114 medicines given the green light in 2024,… read more.
Eli Lilly and Company announced the FDA approved Zepbound (tirzepatide) as the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. Zepbound… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.